SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Apr 14, 2014

IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: April 14, 2014 · CIK: 0001280776 · Accession: 0001193125-14-142338

Offering / Registration Process Regulatory Compliance Business Model Clarity

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-191711

Date
April 14, 2014
Author
MERRILL LYNCH, PIERCE, FENNER & SMITH
Form
CORRESP
Company
IMMUNIC, INC. (IMUX) (CIK 0001280776)

Letter

April 14, 2014

VIA ELECTRONIC SUBMISSION

Securities and Exchange Commission

Mail Stop 3561

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attn: Jeffrey P. Riedler, Assistant Director

Bryan J. Pitko, Staff Attorney

Re: Vital Therapies, Inc.

Registration Statement Filed on Form S-1

Registration No. 333-191711

Ladies and Gentlemen:

Pursuant to Rule 460 under the Securities Act of 1933, we wish to advise you that we have distributed approximately 2,684 copies of the Preliminary Prospectus issued April 7, 2014 through the date hereof, to underwriters, dealers, institutions and others.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, April 16, 2014 or as soon thereafter as practicable.

[signature page follows]

Very truly yours,
MERRILL LYNCH, PIERCE, FENNER & SMITH

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 April 14, 2014

VIA ELECTRONIC SUBMISSION

 Securities and Exchange
Commission

 Mail Stop 3561

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, DC 20549

Attn:
    Jeffrey P. Riedler, Assistant Director

     Bryan
J. Pitko, Staff Attorney

Re:
    Vital Therapies, Inc.

     Registration Statement
Filed on Form S-1

     Registration No. 333-191711

Ladies and Gentlemen:

 Pursuant to Rule 460 under the
Securities Act of 1933, we wish to advise you that we have distributed approximately 2,684 copies of the Preliminary Prospectus issued April 7, 2014 through the date hereof, to underwriters, dealers, institutions and others.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934,
as amended.

 We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be
accelerated to 4:00 p.m. Eastern Time, on Wednesday, April 16, 2014 or as soon thereafter as practicable.

 [signature page
follows]

 Very truly yours,

MERRILL LYNCH, PIERCE, FENNER & SMITH

INCORPORATED

 CREDIT SUISSE SECURITIES (USA) LLC

As representatives of the

 several Underwriters

By:

MERRILL LYNCH, PIERCE, FENNER & SMITH

                         INCORPORATED

By:

     /s/ Michele A.H. Allong

Name: Michele A.H. Allong

Title:   Authorized Signatory

By: CREDIT SUISSE SECURITIES (USA) LLC

By:

     /s/ Charles Newton

Name: Charles Newton

Title:   Managing Director

 [SIGNATURE PAGE TO
ACCELERATION REQUEST OF THE UNDERWRITERS]